Medication Prescribing

The Food and Drug Administration has issued a final rule requiring new health warnings on cigarette packaging and advertisements.

The Food and Drug Administration has issued a final rule requiring new health warnings on cigarette packaging and advertisements.

The Food and Drug Administration has issued a final rule requiring new health warnings on cigarette packaging and advertisements.

The FDA has approved the first option for the treatment of patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

The Food and Drug Administration has approved the first generic pyrimethamine tablets for the treatment of toxoplasmosis to be used with sulfonamide.

The new drug is the first and only FDA-approved antiemetic for the rescue treatment of postoperative nausea and vomiting among surgical patients for whom prior standard-of-care prophylaxis was not...